MENU
CMPX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Compass Therapeutics (CMPX) Ownership - Who owns Compass Therapeutics?
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies... Show more
Profile
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8099
Employees
32
Web
https://www.compasstherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
373.36M
P/E Ratio
N/A
Total Cash
112.64M
Projected Growth
N/A
Total Debt
6.38M
Revenue
850K
Risk (Beta)
2.06
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
CMPX
Capitalization
373M
P/E Ratio
N/A
Risk (Beta)
2.06
Dividend Yield
N/A
Total Cash
113M
Total Cash/Share
0.81
Total Debt
6.38M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
850K
ROE
N/A
Book Value
110M
P/B Ratio
3.39
Cash Flow
N/A
Earnings
-0.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
14K
Current Ratio
8.33
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-60.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.75
Shares Held By Institutions
248M
Shares Outstanding - Current
138M
Total Liabilities
21.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
86.207
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CMPX showed earnings on May 08, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8099
Employees
32
Web
https://www.compasstherapeutics.com